or
forgot password


Phase 2
18 Years
N/A
Not Enrolling
Both
Lung Neoplasms

Thank you

Trial Information


Inclusion Criteria:



- Have a diagnosis of extensive stage small cell lung cancer and can be treated with
chemotherapy.

- Have received no prior chemotherapy for your disease.

- Have at least one measurable lesion.

- have an adequate performance status.

- Sign an informed consent form.

Exclusion Criteria:

- Have previously received chemotherapy for your lung cancer.

- Have been treated with a investigational drug within the last 30 days. Have
previously completed or withdrawn from this study or any other study investigating
ALIMTA.

- Have received radiation therapy within the last 1-2 weeks.

- Have brain metastasis that is uncontrolled.

- Have active infection or other serious condition.

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

7210

NCT ID:

NCT00051506

Start Date:

Completion Date:

Related Keywords:

  • Lung Neoplasms
  • Neoplasms
  • Lung Neoplasms

Name

Location
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. New York, New York  
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Springdale, Arkansas  
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Los Angeles, California  
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Fort Myers, Florida  
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Burlington, North Carolina  
For additional information regarding investigative sites for this trial, contact the Clinical Trials Support Center at 1-877-CTLILLY(1-877-285-4559) or speak with your personal physician. Charleston, South Carolina